Yahoo Web Search

  1. About 148,000 search results
  1. Jul 17, 2019 · The proposed names are also evaluated for compliance with the World Health Organisation’s International Non-proprietary Name programme. After this rigorous process, a new drug will have a proprietary name, which the manufacturer will use to label and market it.

  2. Nov 01, 2019 · Include the name of the product and its common name if the medicinal product contains only one active substance (member states have the option to derogate from this and to allow reference to the name of the product and the international non-proprietary name (INN) only).

  3. People also ask

    Can drugs be sold in the EU without marketing authorisation?

    What is a generic medicine?

    How do I apply for orphan drug designation outside the EU?

    How do you find a proprietary name for a drug?

  4. Retigabine is the non-proprietary name adopted by the International Non-proprietary Name for Pharmaceuticals Substances Program. In the US and Canada, ezogabine is the non-proprietary name adopted by the United States Adopted Name Council. GlaxoSmithKline and Valeant entered into an exclusive worldwide collaboration agreement for Trobalt™ in ...

  5. International non-proprietary name: pegfilgrastim . Procedure No. EMEA/H/C/004915/0000 . Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted.

  6. Questions and answers: Orphan-designation application. This page lists the questions that sponsors may have on applying for orphan designation. If you have a question that is addressed here, forward your request to 1.

  7. › about-genericsBGMA - About generics

    Unlike most of the rest of Europe, the vast majority of generic medicines in the UK are marketed by the generic name or International Non-proprietary Name (INN). GPs are trained at medical school to write prescriptions by INN except where there is a clinical reason for doing otherwise.

  1. People also search for